Orchard Therapeutics PLC (NASDAQ:ORTX)

0.435
Delayed Data
As of 3:58pm ET
 0.00 / 0.00%
Today’s Change
0.41
Today|||52-Week Range
1.55
-67.05%
Year-to-Date

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for Orchard Therapeutics PLC have a median target of 4.50, with a high estimate of 5.00 and a low estimate of 1.00. The median estimate represents a +934.48% increase from the last price of 0.44.

Analyst Recommendations

The current consensus among 7 polled investment analysts is to Buy stock in Orchard Therapeutics PLC. This rating has held steady since December, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.22
Sales
$4.6M
Reporting Date
Mar 01

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 39.77%
 
 
 
 
 
 
Growthannually -13.31%
 
 
 
 
 
 

Sales

Growthquarterly -21.08%
 
 
 
 
 
 
Growthannually 1,105.61%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.